{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:21:18Z","timestamp":1776709278868,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003786","name":"Hangzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["20201203B306"],"award-info":[{"award-number":["20201203B306"]}],"id":[{"id":"10.13039\/501100003786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2019KY133"],"award-info":[{"award-number":["2019KY133"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023KY957"],"award-info":[{"award-number":["2023KY957"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The immune status of <jats:italic>mycobacterium tuberculosis<\/jats:italic> (<jats:italic>MTB<\/jats:italic>) infection is essential for the diagnosis and treatment of this disease. In this work, we aim to evaluate the clinical significance of the combination of serum IFN-\u03b3, IGRAs (Interferon-Gamma Release Assay), lymphocyte subset with activation indicators detection in active and latent tuberculosis infection patients. For this study, anticoagulant\u00a0whole blood were collected from 45 active tuberculosis (AT group), 44 latent tuberculosis (LT group) and 32 healthy controls (HCs group). The serum IFN-\u03b3 and IGRAs detected by chemiluminescence, and the percentage of lymphocyte subsets and activated lymphocytes detected by flow cytometry. The results showed combined IGRAs, serum IFN-\u03b3 and NKT cells not only has good diagnostic efficiency for the AT, but also provides a laboratory diagnostic method to distinguish AT from LT. Activation indicator of CD3<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>+<\/jats:sup>T and CD4<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>+<\/jats:sup>T can effectively distinguish LT from HCs. While combined CD3<jats:sup>+<\/jats:sup>T, CD4<jats:sup>+<\/jats:sup>T, CD8<jats:sup>+<\/jats:sup>CD28<jats:sup>+<\/jats:sup>T, Treg and CD16<jats:sup>+<\/jats:sup>CD56<jats:sup>+<\/jats:sup>CD69<jats:sup>+<\/jats:sup> cells can distinguish AT from HCs. This study showed combined direct detection of serum IFN-\u03b3 and IGRAs as well as lymphocyte subsets with activation indicators which may provide laboratory basis for the diagnosis and differential diagnosis of active and latent <jats:italic>MTB<\/jats:italic> infection.<\/jats:p>","DOI":"10.1007\/s00284-023-03306-z","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:02:16Z","timestamp":1682582536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined Detection of IFN-\u03b3 and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times"],"prefix":"10.1007","volume":"80","author":[{"given":"Yiwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lahong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"3306_CR1","volume-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) Global tuberculosis report 2020. World Health Organization, Geneva"},{"issue":"1","key":"3306_CR2","first-page":"30","volume":"41","author":"Y Shuo","year":"2021","unstructured":"Shuo Y, Le W, Xiaotong Y et al (2021) Changes in peripheral blood lymphocyte subsets in children with active tuberculosiss. Chin J Microbiol Immunol 41(1):30\u201335","journal-title":"Chin J Microbiol Immunol"},{"key":"3306_CR3","volume-title":"Latent tuberculosis infection: updated, consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) Latent tuberculosis infection: updated, consolidated guidelines for programmatic management. World Health Organization, Geneva"},{"issue":"s1","key":"3306_CR4","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1086\/518659","volume":"196","author":"BJ Marais","year":"2007","unstructured":"Marais BJ, Graham SM, Cotton MF et al (2007) Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 196(s1):S76\u2013S85","journal-title":"J Infect Dis"},{"issue":"9","key":"3306_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.2016.11021","volume":"316","author":"HM Blumberg","year":"2016","unstructured":"Blumberg HM, Ernst JD (2016) The challenge of latent TB infection. JAMA 316(9):931\u2013933","journal-title":"JAMA"},{"issue":"9","key":"3306_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.4014\/jmb.1202.02032","volume":"22","author":"LJ Jiang","year":"2012","unstructured":"Jiang LJ, Wu WJ, Wu H et al (2012) Rapid detection and monitoring therapeutic efficacy of mycobacterium tuberculosis complex using a novel real-time assay. J Microbiol Biotechnol 22(9):1301\u20131306","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"3306_CR7","first-page":"170","volume":"111","author":"JP Zellweger","year":"2020","unstructured":"Zellweger JP, Sotgiu G, Corradi M et al (2020) The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and prespectives to eliminate tuberculosis (TB). Med lav 111(3):170\u2013183","journal-title":"Med lav"},{"issue":"Suppl 2","key":"3306_CR8","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1093\/infdis\/jis043","volume":"205","author":"S Brighenti","year":"2012","unstructured":"Brighenti S, Andersson J (2012) Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis 205(Suppl 2):S316-324","journal-title":"J Infect Dis"},{"issue":"3","key":"3306_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/mi.2011.3","volume":"4","author":"SM Behar","year":"2011","unstructured":"Behar SM, Martin CJ, Booty MG et al (2011) Apopotos is an innate defense function of macrophages against mycobacterium tuberculosis. Mucosal Immunol 4(3):279\u2013287","journal-title":"Mucosal Immunol"},{"issue":"6","key":"3306_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","volume":"64","author":"K Chang","year":"2012","unstructured":"Chang K, Lu W, Wang J et al (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis. Journal Infection 64(6):580\u2013588","journal-title":"Journal Infection"},{"issue":"4","key":"3306_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","volume":"163","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, McShane H et al (2001) Rapid detection of mycobacterium tuberculosis infection by enumeration of antigen-specific t cells. Am J Respir Crit Care Med 163(4):824\u2013828","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-5","key":"3306_CR12","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A et al (2010) Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection USA. MMWR Recomm Rep 59(RR-5):1\u201325","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"3306_CR13","first-page":"59","volume":"3","author":"People's Republic of China state health and Family Planning Commission","year":"2018","unstructured":"People\u2019s Republic of China state health and Family Planning Commission (2018) Tuberculosis diagnostic criteria (WS 288\u20132017). Electron J Emerg Infect Dis 3(1):59\u201361","journal-title":"Electron J Emerg Infect Dis"},{"issue":"3","key":"3306_CR14","first-page":"191","volume":"3","author":"People's Republic of China state health and Family Planning Commission","year":"2018","unstructured":"People\u2019s Republic of China state health and Family Planning Commission (2018) Tuberculosis classification (WS196\u20142017). Electron J Emerg Infect Dis 3(3):191\u2013192","journal-title":"Electron J Emerg Infect Dis"},{"key":"3306_CR15","first-page":"019","volume":"06","author":"L Fu","year":"2019","unstructured":"Fu L, Liang J, Zhang GL et al (2019) \u03b3\u03b4T cells in tuberculosis immunotherapy and future prospects. Chin J Antitubercul 06:019","journal-title":"Chin J Antitubercul"},{"issue":"10","key":"3306_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","volume":"177","author":"R Diel","year":"2008","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K et al (2008) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis. Am J Respir Crit Care Med 177(10):1164\u20131170","journal-title":"Am J Respir Crit Care Med"},{"key":"3306_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5493\/wjem.v2.i4.70","volume":"2","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Sugawani I (2012) Immunology of tuberculosis. World J Exp Med 2:70\u201374","journal-title":"World J Exp Med"},{"key":"3306_CR18","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.4049\/jimmunol.162.11.6410","volume":"162","author":"G Ebel","year":"1999","unstructured":"Ebel G, Lees R, Smiley ST et al (1999) Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J Immunol 162:6410\u20136419","journal-title":"J Immunol"},{"issue":"1","key":"3306_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Ann Rev Immunol 27(1):393\u2013422","journal-title":"Ann Rev Immunol"},{"key":"3306_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/srep00216","volume":"2","author":"Z Qiu","year":"2012","unstructured":"Qiu Z, Zhang M, Zhu Y (2012) Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep 2:216","journal-title":"Sci Rep"},{"issue":"6","key":"3306_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tube.2007.07.004","volume":"87","author":"L Li","year":"2007","unstructured":"Li L, Lao SH, Wu CY (2007) Increased frequency of CD4(+) CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients. Tuberculosis 87(6):526\u2013534","journal-title":"Tuberculosis"},{"issue":"2","key":"3306_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bjid.2016.10.011","volume":"21","author":"J Luo","year":"2016","unstructured":"Luo J, Zhang M, Yan B et al (2016) Imbalance of Th17 and Treg in peripheral blood mononuclear cells of active tuberculosis patients. Brazilian Journal of Infectious Diseases 21(2):155\u2013161","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"3","key":"3306_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/gyno.1995.1243","volume":"58","author":"K Miyazaki","year":"1995","unstructured":"Miyazaki K, Shimada K, Katabuchi H et al (1995) Activated (HLA-HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors. Gynecol Oncol 58(3):362\u2013367","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3306_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2004.12.006","volume":"26","author":"D Sancho","year":"2005","unstructured":"Sancho D, G\u00f3mez M, S\u00e1nchez-MaHLA-DRid F (2005) CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26(3):136\u2013140","journal-title":"Trends Immunol"},{"issue":"5","key":"3306_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/stem.5530120502","volume":"12","author":"SF Ziegler","year":"1994","unstructured":"Ziegler SF, Ramsdell F, Alderson MR (1994) The activation antigen CD69. Stem Cells 12(5):456\u2013465","journal-title":"Stem Cells"},{"issue":"3","key":"3306_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1365-3083.2010.02496.x","volume":"73","author":"I Wergeland","year":"2011","unstructured":"Wergeland I, JA, Mus J, Dyrhol-Riise AM, (2011) T Regulatory Cells and Immune Activation in Mycobacterium tuberculosis Infection and the Effect of Preventive Therapy. Scand J Immunol 73(3):234\u2013242","journal-title":"Scand J Immunol"},{"issue":"6","key":"3306_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.clinre.2017.03.009","volume":"41","author":"SX Dai","year":"2017","unstructured":"Dai SX, Gu HX, Lin QY et al (2017) CD8+ CD28+ \/CD8+ CD28-, T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clin Res Hepatol Gastroenterol 41(6):693\u2013702","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03306-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T02:02:03Z","timestamp":1684720923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03306-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03306-z","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Hangzhou Normal University Affiliated Hospital, China. 2019 (E02)-HS-05, 2021 (E2)-HS-004, 2022 (E2)-HS153.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}],"article-number":"193"}}